Skip to main content

Table 4 Therapy with insulin and other antihyperglycemic medications at the time of visit (n = 241)

From: Glycemic control of adult patients with type 1 diabetes mellitus in Arabian Gulf Countries; PREDICT

Antihyperglycemic Therapy Count (%)
Basal Insulin
 Long-acting insulin analog 138 (57.3)
 New generation of long-acting basal insulin 81 (33.6)
 Intermediate-acting human insulin 3 (1.2)
Prandial Insulin
 Rapid-acting insulin analog 200 (83.0)
 Short-acting human insulin 24 (10.0)
Premix Insulin
 Premixed analog insulin 10 (4.1)
 Premixed human insulin 2 (0.8)
Other antihyperglycemic medications
 Metformin 20 (8.3)
 DPP4a inhibitors 7 (2.9)
 SGLT2b inhibitors 2 (0.8)
 GLP1c receptor agonists 3 (1.2)
 Fixed dose combination of DPP4 inhibitor / Metformin 6 (2.5)
  1. Note: Patient could have received more than 1 insulin type and more than 1 antihyperglycemic drug
  2. a DPP4 dipeptidyl peptidase-4, b SGLT2 sodium-glucose cotransporter-2, c GLP1 glucagon-like peptide-1